(Total Views: 669)
Posted On: 01/26/2022 3:00:10 PM
Post# of 153887
CDiddy,
We should see stellar results in Brazil. Long haulers provide a huge opportunity, but it is a heterogenous disorder without clear biomarkers to track and without even clear definitions.
I believe that LH trials could be a quagmire. Expectations of what constitutes success need to be determined by the FDA.
IMO, Cytodyn will be there eventually, just not quite yet.
After success in Brazil and approval, other opportunities can be explored.
GLTU
We should see stellar results in Brazil. Long haulers provide a huge opportunity, but it is a heterogenous disorder without clear biomarkers to track and without even clear definitions.
I believe that LH trials could be a quagmire. Expectations of what constitutes success need to be determined by the FDA.
IMO, Cytodyn will be there eventually, just not quite yet.
After success in Brazil and approval, other opportunities can be explored.
GLTU
(4)
(0)
